scispace - formally typeset
R

Rajender

Researcher at Indian Institute of Chemical Technology

Publications -  7
Citations -  190

Rajender is an academic researcher from Indian Institute of Chemical Technology. The author has contributed to research in topics: Pyrrolobenzodiazepine & Apoptosis. The author has an hindex of 6, co-authored 7 publications receiving 173 citations.

Papers
More filters
Journal ArticleDOI

Remarkable enhancement in the DNA-binding ability of C2-fluoro substituted pyrrolo(2,1-c)(1,4)benzodiazepines and their anticancer potential

TL;DR: This study illustrates the importance of introducing fluoro substitution at the C2-position apart from the incorporation of a piperazine ring in between the alkyloxy linker for enhancement of the DNA-binding ability in comparison to DSB-120 and SJG-136.
Journal ArticleDOI

Synthesis of terphenyl benzimidazoles as tubulin polymerization inhibitors.

TL;DR: Compounds 3t and 3ad are the most promising candidates amongst the series and has the potential to be taken up for further detailed studies either alone or in combination with the existing therapies.
Journal ArticleDOI

Design, synthesis and biological evaluation of imidazopyridine/imidazopyrimidine-benzimidazole conjugates as potential anticancer agents

TL;DR: The present study demonstrates that the synthesis of imidazopyridine/imidZopyrimidine-benzimidazole conjugates as promising tubulin inhibitors with G2/M phasecell cycle arrest and apoptotic-inducing ability.
Journal ArticleDOI

Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.

TL;DR: Interestingly, compounds 5b and 6b have been identified as a new class of inhibitors of tubulin polymerization and their action has been rationalized by the cell cycle arrest in G0 and G2/M phase.
Journal ArticleDOI

Synthesis of Aryl-Substituted Naphthalene-Linked Pyrrolobenzodiazepine Conjugates as Potential Anticancer Agents with Apoptosis-Inducing Ability

TL;DR: A library of new aryl‐substituted naphthalene C8‐linked pyrrolo[2,1‐c][1,4]benzodiazepine (PBD) conjugates with various linker architectures with anticancer potential were designed, synthesized, and evaluated for their anticancer activity against a panel of 11 human cancer cell lines.